降脂药物治疗病人需住院肌溶解症的发生率

首页> 中文期刊>美国医学会杂志：中文版 >降脂药物治疗病人需住院肌溶解症的发生率

页面导航

摘要

@@ 背景:在美国降脂药物已获广泛应用.但是对各种降脂药物发生肌溶解症的危险性目前尚缺乏可靠的估计.rn目的:对门诊情况下,不同他汀及贝特类药物(单用或联用)治疗病人肌溶解症的发生率进行估计.

来源
《美国医学会杂志：中文版》|2006年第1期|28-33|共6页
作者
David J Graham; Richard Platt; 徐成斌; Judy A Staffa; Deborah shatin; Susan E. Andrade; Stephanie D Schech; Lois La Grenade; Jerry H. Gurwitz; K. Arnold Chan; Michael J. Goodman;
展开▼
作者单位

Office;

of;

Drug;

Safety,;

Center;

for;

Drug;

Evaluation;

and;

Research,;

Food;

and;

Drug;

Administration,;

Rockvilte,;

Md;

Center;

for;

Health;

Care;

Policy;

and;

Evaluation,;

Eden;

Prairie,;

Minn;

Meyers;

Pdmary;

Care;

Institute,;

Fallon;

Foundation;

and;

the;

University;

of;

Massachusetts;

Medical;

School,;

Worcester;

Channing;

Laboratory,;

Brigham;

and;

Wornen＇s;

Hospital;

and;

Harvard;

Medical;

School;

Department;

of;

Ambulatory;

Care;

and;

Prevention,;

Harvard;

Pilgrim;

Health;

Care;

and;

Harvard;

Medical;

School;

Department;

of;

Epiderniology,;

HarvardSchool;

of;

Public;

Health;

Boston,;

Massi;

and;

HealthPartners;

Research;

Founda＇don,;

Minneapolis,;

Minn;

不详;

展开▼
原文格式 PDF
正文语种 chi
中图分类药学;
关键词
药物治疗; 糖尿病人; 降脂药物; 肌溶解; 发生率; 住院; 贝特类药物; 阿托伐他汀; interval; 卫生保健计划;